The China Study by Thomas Campbell

(nextflipdebug5) #1


  1. Cairns]. "The treatment of diseases and the War against Cancer." Sci. Am. 253 (1985):

  2. CuzickJ, and Baum M. "Tamoxifen and contralateral breast cancer." Lancet 2 (1985): 282.

  3. CuzickJ, Wang DY, and Bulbrook RD. "The prevention of breast cancer." Lancet 1 (1986):

  4. Fisher B, Costantino JP, Wickerham DL, et a!. "Tamoxifen for prevention of breast cancer:
    report of the National Surgical Adjuvant Breast and Bowel Project P-l Study" j. Nat. Cancer
    Inst. 90 (1998): 1371-1388.

  5. Freedman AN, Graubard BI, Rao SR, et a!. "Estimates of the number of U.S. women who
    could benefit from tamoxifen for breast cancer chemoprevention." j. Nat. Cancer Inst. 95
    (2003): 526--532.

  6. Powles T, Eeles R, Ashley S, et a!. "Interim analysis of the incidence of breast cancer in the
    Royal Marsden Hospital tamoxifen randomised chemoprevention tria!''' Lancet 352 (1998):

  7. Veronesi U, Maisonneuve P, Costa A, et a!. "Prevention of breast cancer with tamoxifen: pre-
    liminary findings from the Italian randomised trial among hysterectomised women." Lancet
    352 (1998): 93-97.

  8. CuzickJ. "A brief review of the current breast cancer prevention trials and proposals for
    future trials." Eur J Cancer 36 (2000): 1298-1302.

  9. Cummings SR, Eckert S, Krueger KA, et a!. "The effect of raloxifene on risk of breast cancer
    in postmenopausal women: results from the MORE randomized tria!." JAMA 281 (1999):

  10. Dorgan JF, Hunsberger S, A., McMahon RP, et a!. "Diet and sex hormones in girls: findings
    from a randomized controlled clinical tria!''' j. Nat. Cancer Inst. 95 (2003): 132-141.

  11. Ornish D, Scherwitz LW, BillingsJH, et a!. "Intensive lifestyle changes for reversal of coronary
    heart disease." JAMA 280 (1998): 2001-2007.

  12. Esseistyn CB, Ellis SG, Medendorp Sv, et a!. "A strategy to arrest and reverse coronary artery
    disease: a 5-year longitudinal study of a single physician's practice." j. Family Practice 41
    (1995): 560-568.

  13. Hildenbrand GLG, Hildenbrand LC, Bradford K, et a!. "Five-year survival rates of melanoma
    patients treated by diet therapy after the manner of Gerson: a retrospective review." Alterna-
    tive Therapies in Health and Medicine 1 (1995): 29-37.

  14. Youngman LD, and Campbell TC. "Inhibition of aflatoxin Bl-induced gamma-glutamyl
    transpeptidase positive (GGT+) hepatic preneoplastic foci and tumors by low protein diets:
    evidence that altered GGT+ foci indicate neoplastic potentia!." Carcinogenesis 13 (1992):

  15. Ronai Z, Gradia S, El-Bayoumy K, et a!. "Contrasting incidence of ras mutations in rat mam-
    mary and mouse skin tumors induced by anti-benzo!clphenanthrene-3,4-diol-l,2-epoxide."
    Carcinogensis 15 (1994): 2113-2116.

  16. Jeffy BD, Schultz EU, Selmin 0, et a!. "Inhibition of BRCA-l expression by benzo!alpyrene
    and diol epoxide." Mol. Carcinogenesis 26 (1999): 100-118.

  17. Gammon MD, Santella RM, Neugut AI, et a!. "Environmental toxins and breast cancer on
    Long Island.!. Polycyclic aromatic hydrocarbon DNA adducts." Cancer Epidemiol Biomarkers
    Prev 11 (2002): 677-685.

  18. Gammon MD, Wolff MS, Neugut AI, et a!. "Environmental toxins and breast cancer on Long
    Island. II. Organchlorine compound levels in blood." Cancer Epidemiol Biomarkers Prev 11
    (2002): 686-697.

  19. Humphries KH, and Gill S. "Risks and benefits of hormone replacement therapy: the evi-
    dence speaks." Canadian Med. Assoc. Joum. 168 (2003): 1001-1010.

  20. Writing Group for the Women's Health Initiative Investigators. "Risks and benefits of estro-

Free download pdf